Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-08

Clinical Trial Update: Ketamine for OUD and Suicidal Ideation in the ED [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ketamine for opioid use disorder and suicidal ideation in the emergency department has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Opioid Use Disorder, Suicidal Ideation | Phase 2 | Status: TERMINATED